chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the Shingles 9-10 days after the first Pfizer Vaccine on 17Mar2021. I felt the first bumps late night on 26Mar2021; This is a spontaneous report from a contactable consumer. A 51-years-old female patient received bnt162b2 (Formulation: Solution for injection; Solution for injection; Batch/Lot Number: EP7534), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 15:00 PM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included fibromyalgia and uterine cancer from an unknown date and unknown if ongoing. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and gabapentin (GABAPENTIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 23:00 PM patient experienced shingles I got the Shingles 9-10 days after the first Pfizer Vaccine on 17Mar2021. I felt the first bumps late night on 26Mar2021. Diagnosed 29Mar2021. ae resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with Higher doses of Gabapentin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
FATIGUE ALLERGIES BODY ACHES HIP PAIN NAUSEA SMALL JOINT PAIN
Pain at injection site, neck stiffness, muscle cramps, dizziness, nausea, insomnia, tiredness, shivering
After the shot patient said it was making him feel sick and when he got home he passed out in the bathroom was sweating and was pale as a ghost and was very lightheaded.
pain under Lt arm - by armpit. Pain is caused by anything touching the axilla area. No discharge noted.
pt devel facial burning & itching @ 4 pm; exam 18dec96 @ 10am revealed facial, neck & upper trunk urticaria. tx: seldane 60mg.
asked for Covid booster and signed up for Moderna clinic. (Employee had recieved 2  previous doses of Pfizer  from a pharmacy) Asked if she wanted Moderna for booster since had done Pfizer and responded ,"well CDC says doesn't matter which, right?" so told her CDC guidelines said fine. Approximately 20 minutes after receiving booster she came to me showing both forearms had developed a rash so sent to a local medical center which is directly above our clinic. She returned to work a bit before lunchtime.
Pt was to receive 0.25 ml booster dose Sars-2-COVID, instead received 0.50ml dose. Denies symptoms.
pain in right arm and back into the right shoulder blade> increased through out the follow week developing around  day 10 into not being able to rise the right arm without pain. Symptoms increased into fatigue, flu like systemic reactions of whole body agitated, over stimulated electric like quality. Mental agitation. Started using Tylenol every 6 hours for pain. Started icing arm. Emotionally draining. 4/21/21 arm started not to be painful for lifting. Very emotional. Systemic agitation starting to calm down on the 22nd of April.
Associate noticed that the top of his feet were itching.  Associate woke up later that morning and realized he had hives on his feet, arms, and hands.
Severe an anaphylaxis, throat swollen, eyes/face/lips swollen. High HR, sneezing coughing, severe fatigue, severe runny nose,  along withCovid-like symptoms.
It was reported that a 29 year old female received Td Adult on 10/21/02. At an unspecified time following vaccination, she experienced a fever of 36.5C and redness at the injection site measuring four centimeters. Additionally, she experienced nausea and vomiting and was unable to hold anything down. She was dehydrated from the nausea and vomiting and was receiving IV fluids. Per the nurse practitioner at the ER, they were going to try antihistamines and antiemetics. It was not reported whether the pt recovered. Seriousness criteria: other medically significant (OMIC).
vaccine was stored in the freezer instead of the fridge and was administered to the patient No adverse reactions have been reported.
Initially after injection, felt fine. Within approx. 20-30 minutes, hands began to get clammy and sweaty. Hot flashes in feet and a slight feeling of lightheadedness. Symptoms lasted approx. 30-45 minutes.
I went to my annual physical and I found out I was anemic. He suggested a colonoscopy and endoscopy. Never had this in previous bloodwork.
High temperature up to 103.2F.  Hypertensive episode 165/105 with temporary blurry vision. Three days of high fevers otherwise 101-102 despite alternating Tylenol and Ibuprofen every 3-4 hours and hydrating. Also had an additional episode of hypertension with blurry vision when I wasn't febrile.
Information has been received from a nurse concerning a 4 year old male who on 16-JUN-2009 was vaccinated with a dose of VARIVAX (Merck) (lot # 663536/0263Y, 0.5ml, subcutaneous injection).  Concomitant therapy included DTAP (unspecified) and IPV (unspecified) given on the same day.  On approximately 17-JUN-2009 ("within a day or 2 of the injection") the patient developed redness and warmth at the injection site.  The patient had sought medical attention.  The events improved on an unspecified date.  This is one of several reports from the same source.  Additional information has been requested.
Had varicella injection left arm on 4/19/18 and area turned red/hot with small pustules 4 days later.
Localized redness surrounding injection site.  Approx 5 cm circular redness mild swelling and warmness.  Advised topical benedryl to area twice daily for 3-5 days.  Also advised holding pressure for 3-5 minutes after next injection.  Patient reports improvement over the past 4 days.
Local adverse reaction to DTaP vaccine left deltoid red raised area, swollen and hot, approx. 8cm in diameter.
07/2021 vaccination Almost immediately, pain in arm after vaccination. Never went away and got worse, several months after.  Woke up to arm being numb on that side, months later but that got better. At first I had thought it was a heart attack, but I was so tired and waited for it to go away. Once it did, I went back to sleep on the other side.  The Dr. and cardiologist 'didn't listen to me' about the pain. I guess if I am walking, I am ok. I don't trust doctors anymore.
left side chest pain like someone was pushing down on chest; shortness of breath/hurts to take a deep breath in; Flu like symptoms; lightheaded; cold tingling sensation along both arms and both legs; very tired; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (left side chest pain like someone was pushing down on chest), DYSPNOEA (shortness of breath/hurts to take a deep breath in), INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (lightheaded) and PARAESTHESIA (cold tingling sensation along both arms and both legs) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017E21A and 088D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PARAESTHESIA (cold tingling sensation along both arms and both legs) and FATIGUE (very tired). August 2021, the patient experienced DIZZINESS (lightheaded). On 30-Aug-2021, the patient experienced CHEST PAIN (left side chest pain like someone was pushing down on chest) and DYSPNOEA (shortness of breath/hurts to take a deep breath in). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Sleeplessness, at a dose of Unknown and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Sleeplessness, at a dose of Unknown. At the time of the report, CHEST PAIN (left side chest pain like someone was pushing down on chest) and DYSPNOEA (shortness of breath/hurts to take a deep breath in) had not resolved and INFLUENZA LIKE ILLNESS (Flu like symptoms), DIZZINESS (lightheaded), PARAESTHESIA (cold tingling sensation along both arms and both legs) and FATIGUE (very tired) outcome was unknown.            No concomitant medication were reported.   This case was linked to MOD-2021-301521 (Patient Link).
p/vax pt became preg;LMP was 2/25/98;pt sought unspecified medical attention;
Severe dizziness, weakness, generalized body aches, nausea, headache.
Parent reports 1/2 dollar sized erythema right upper arm that next day after shot and slight increased next day. Larger today - measured 4inx5in diameter here in office. Right upper deltoid region - firm, hot, indurated, non-tender, red. Treated with Zyrtec 1tsp PO QD until decreased swelling.`
This case was reported by a consumer via call center representative and described the occurrence of throat blister in a 71-year-old female patient who received SHINGRIX for prophylaxis. On 11th March 2019, the patient received the 1st dose of SHINGRIX. On 12th March 2019, 1 days after receiving SHINGRIX, the patient experienced throat blister (serious criteria GSK medically significant) and tongue blistering. On an unknown date, the outcome of the throat blister and tongue blistering were not recovered/not resolved. It was unknown if the reporter considered the throat blister and tongue blistering to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on left arm and next day, she woke up with blisters on the back of the tongue that had progressed down her throat. The reporter consented to follow up.
Patients received dose from a punctured vials in the refrigerator for days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received dose from a punctured vials in the refrigerator for days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received dose from a punctured vials in the refrigerator for days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received dose from a punctured vials in the refrigerator for days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported.  It was reported that patients were vaccinated with vaccine which was punctured for more than 6 hours and placed back into the refrigerator for multiple days. It was not confirmed whether it was first or second dose of vaccine.
developed "plantar warts" on his hands sometime after the GARDASIL 9 series was completed on an unspecified date.; Information has been received from a patient's mother who is also the medical assistant via a field representative referring to a currently 17 years old (also reported as currently 15 years old) male patient. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were unknown.     In 2013 (reported as when he was eleven years old), the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (batch/lot # and expiration date were not reported) intramuscularly for prevention of Human Papilloma Virus (HPV) disease and cancers. On 24-JUN-2013, his second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (batch/lot # and expiration date were not reported) was administered. On an unspecified date, the patient was vaccinated with the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (batch/lot # and expiration date were not reported).   On an unknown date after the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) series was completed, the patient developed "plantar warts" on his hands. The patient had sought medical attention. The reporter reported treatment included having the plantar warts "shaved off and treated" on unspecified dates. The reporter reported the plantar warts had not resolved and this was an "ongoing issue".  The causality was not reported.
This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with the first dose of VARIVAX, dose, route and frequency unknown. On 20-MAY-2013, the patient was vaccinated with improperly stored VARIVAX dose 2, lot#: 0610AE. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Woke up early in morning next day after receiving PPV 23 and flu shots feeling sick, with difficulty raising R arm (arm that got PPV 23 shot), whole R side of body ached, swollen R axillary lymph nodes, redness and pain in underarm area.
pt was irritable x 2wk p/vax;cried inconsolably x 3 days p/vax & cont to cry on & off through the week p/vax;low grade fever present through first week;
Cold; Feel awful; Scared; Sick; Feverish; This spontaneous case was reported by an other health care professional and describes the occurrence of NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feel awful), FEAR (Scared), ILLNESS (Sick) and PYREXIA (Feverish) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jun-2021, the patient experienced NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feel awful), FEAR (Scared), ILLNESS (Sick) and PYREXIA (Feverish). At the time of the report, NASOPHARYNGITIS (Cold), FEELING ABNORMAL (Feel awful), FEAR (Scared), ILLNESS (Sick) and PYREXIA (Feverish) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Patient presented to the ED with chest pain  and was subsequently hospitalized. Diagnosis was NSTEMI. This was within 6 weeks of receiving COVID vaccination.
Information has been received from a physician concerning a 19 month old female patient with pertinent medical history unknown who on 10-AUG-2009 was vaccinated with a dose of VARIVAX (Merck) lot number 661869/1010X. Secondary suspect therapy included MMR II (MSD). On 30-AUG-2009 the physician reported that the patient who had received VARIVAX (Merck) developed diffuse lesions on her chest and arms. The physician reported that the patient had 3 large papules and 2 small papules. At the time of this report the patient had not recovered. The patient sought medical attention in the physician office. Follow-up information has been received from the physician who reported that the 21 month year old female patient (previously reported as 19 month year old) with amoxicillin allergy on 10-AUG-2009 was vaccinated with the first dose of MMR II (MSD) subcutaneously at her right lat and with a dose of BOOSTRIX (Lot# AC20B116AB) into her left thigh. There was no illness at the time of vaccination. On 02-SEP-2009 (approximately at 09:00 am) the patient developed vesicular lesions less than 50, 3 larges papules, 2 small pustules and diffusive lesions in chest and arms. On 05-SEP-2009, the patient recovered from vesicular lesions, pustules and diffusive lesions. No further information is available.
This spontaneous report as received from a pharmacist refers to a 87 years old female patient with allergy to PNEUMOVAX (MARRS# 1302USA000541) and no pertinent medical history. On 19-JAN-2013 the patient was subcutaneously vaccinated with a 0.65 ml dose of ZOSTAVAX (lot # H018497, exp. date; 10-JAN-2014) for shingles prevention. There was no concomitant medication. It was reported that the following day on 20-JAN-2013 the patient had a "red line" going down her arm from the site of injection about 3.4 inches wide and approximately 3 to 4 inches long. According to the patient the line had not increased in length or width but was still visible. There was no treatment for the event. The patient did not seek medical attention other than call the Pharmacist today, 22-JAN-2013. None lab diagnostics studies were performed. The relatedness for the event was unknown for ZOSTAVAX. This is one of several reports received from the same patient. Additional information has been requested.
Ache in right deltoid muscle, like a toothache.  Feels like a deep ache.  Continued all evening and night, kept her awake.  Took 01:00 took a Darvocet and at 03:00 took a Percocet and received no relief of pain.  States having some shooting pain.  Rates pain 8/10.  At this time no relief.  Encouraged to put ice on it, given Ibuprofen 400 mg po x once.  RN
Information has been received from a licensed visiting nurse concerning a 67 year old female with drug hypersensitivity to codeine, PPD and ZYBAN who on 14-JAN-2009 was vaccinated with ZOSTAVAX (LOT # 662757/1622X). 3 days later, on 17-JAN-2009 the. The patient came into the office to report the shingles, but was not seen by a HCP. The shingles had not been confirmed. Office might be interested in PCR identification. The patient's shingles was not recovered. It was reported that the patient sought unspecified medical attention. Additional information has been requested.
Febrile seizure 05/16/07. Hospital DC 5/17/08 neurology consult EEG-NC. Family Hx epilepsy Co serve hive.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm hurt a little bit) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21B) for COVID-19 vaccination. Allergy includes Cat, dogs, penicillin and some other antibiotics. The patient's past medical history included Glaucoma (for 35 years). Concurrent medical conditions included Allergy to animal, Allergy to animal, Penicillin allergy and Allergy to antibiotic. On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Left arm hurt a little bit). At the time of the report, VACCINATION SITE PAIN (Left arm hurt a little bit) outcome was unknown. Concomitant medications included anti-glaucoma drops. Treatment information included Sea sick pills. This case was linked to MOD-2022-532669 (Patient Link).
Soreness at the injection site/spread from the injection site and down to the patient's elbow; Injection site itchy/symptoms spread from the injection site and down to the patient's elbow; Rash at the injection site/symptoms spread from the injection site and down to the patient's elbow; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number E99e7, expiry date 11th May 2023) for prophylaxis.   On 10th December 2021, the patient received the 1st dose of Shingrix. On 11th December 2021, less than a day after receiving Shingrix, the patient experienced pain in arm, itchy upper limbs and rash. On an unknown date, the outcome of the pain in arm, itchy upper limbs and rash were recovered/resolved.   It was unknown if the reporter considered the pain in arm, itchy upper limbs and rash to be related to Shingrix.  Additional details reported were as follows: The patient received Shingrix in left deltoid. A day after receiving Shingrix, the patient experienced soreness, itchiness, and a rash on the same side as the injection. The symptoms spread from the injection site and down to the patient's elbow. The symptoms were 4 to 5 days in duration. There were no breathing issues noted. The reporter consented to follow up.
Experienced warm feeling, nausea and itching of lips within 10 minutes of administration.  After approximately 40 minutes noted itching in throat. Returned to vaccination area approximately 60 minutes after injection for guidance and instructed to ED. Noticed lip swelling and facial swelling later in ED, had mask on entire duration, did not note when first occurred. Lip itching, throat itching relieved with Benadryl, prednisone and pepcid all given  po, released to home after 4 hours observation. Throat itching persists on day 2, some relief with benadryl Q 4 hours.
This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 75-year-old female patient who received SHINGRIX (batch number G45LN, expiry date 13th March 2021) for prophylaxis. On 12th February 2019, the patient received the 1st dose of SHINGRIX (intramuscular). In February 2019, less than a week after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site erythema and injection site rash. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema and injection site rash were not recovered/not resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site erythema and injection site rash to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left deltoid. The pharmacist reported that the patient experienced a red swollen spot that was approximately 3-4 inches in diameter at the injection site. The spot was raised and was on the patient's left deltoid. The symptoms are resolving but the patient came at the time of reporting and the area was still unresolved. Consent to follow up was provided.
After 12 hours I got mild fever , body ache severe weakness pain in my joints all over body and lower back buttocks area , head ache ,
Pt had 3 vaccines administered 10/24/16 in her right arm. Had mild flu like sx and redness; pain in right arm today.
Received An Expired Dose; Initial Report Received 14-Mar-2023  This is a spontaneous report received from a Certified Medical Assistant (CMA) who reported that a 26-year-old female who received HEPLISAV-B for Hepatitis B immunization received an expired dose of HEPLISAV B.     There were no medications or additional medical history provided.  The patient was not pregnant at the time.   On 13-Mar-2023, dose 1 of HEPLISAV-B (Lot# 937233, NDC 43528-003-01, Expiration Date 11-Mar-2023) was administered intramuscularly in the right deltoid.    On 13-Mar-2023, the patient received HEPLISAV-B that was 2 days past the expiration date.  There were no adverse reactions reported.    No additional information was provided.  Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
The patient experienced a fever, chills, myalgia, nausea and fatigue after vaccination.